Ep. 82 "The New Normal for Treating Moderate-to-Severe Plaque Psoriasis" A Sun Pharma sponsored podcast

Psound Bytes

English - July 16, 2020 08:00 - 32 minutes - 44.4 MB - ★★★★★ - 36 ratings
Medicine Health & Fitness Education healthandwellness arthritis chronicillness npf psoriasis psoriatic psound skin skincondition Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. 81 CME .5 "Use of Systemic Nonbiologic Therapies for Psoriatic Disease Now and in the Future"

Next Episode: Ep. 83 "Tips for Making Telehealth Psoriasis Visits Successful"

Hear George Han, M.D. of the Icahn School of Medicine at Mt. Sinai, and Mark Kaufmann, M.D., President-Elect at the American Academy of Dermatology, discuss the new normal for dermatologists and learn about ILUMYA™ (tildrakizumab-asmn), a treatment for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For Important Safety Information: https://bit.ly/2We7fIS. For Full Prescribing Information: https://bit.ly/2xLEfil.